Cargando…

Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: Regulation of MMP 9 by PDEF

BACKGROUND: Prostate-derived Ets factor (PDEF) is expressed in tissues of high epithelial content including prostate, although its precise function has not been fully established. Conventional therapies produce a high rate of cure for patients with localized prostate cancer, but there is, at present...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johnson, Thomas R, Koul, Sweaty, Kumar, Binod, Khandrika, Lakshmipathi, Venezia, Sarah, Maroni, Paul D, Meacham, Randall B, Koul, Hari K
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904725/ https://www.ncbi.nlm.nih.gov/pubmed/20550708 http://dx.doi.org/10.1186/1476-4598-9-148

Ejemplares similares

Retraction Note to: Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: Regulation of MMP 9 by PDEF
por: Johnson, Thomas R., et al.
Publicado: (2021)

Prostate-Derived ETS Factor (PDEF) Modulates Yes Associated Protein 1 (YAP1) in Prostate Cancer Cells: A Potential Cross-Talk between PDEF and Hippo Signaling
por: Jaiswal, Praveen Kumar, et al.
Publicado: (2019)

Hypoxia associated p38 Mitogen Activated Protein Kinase Mediated Androgen Receptor Activation and Increased Hif-1α Levels Contribute to emergence of an Aggressive Phenotype in Prostate Cancer
por: Khandrika, Lakshmipathi, et al.
Publicado: (2009)

Kidney Injury Molecule-1 Is Up-Regulated in Renal Epithelial Cells in Response to Oxalate In Vitro and in Renal Tissues in Response to Hyperoxaluria In Vivo
por: Khandrika, Lakshmipathi, et al.
Publicado: (2012)

Genome Wide Analysis of Differentially Expressed Genes in HK-2 Cells, a Line of Human Kidney Epithelial Cells in Response to Oxalate
por: Koul, Sweaty, et al.
Publicado: (2012)

Mitogen Activated Protein kinase signal transduction pathways in the prostate
por: Maroni, Paul D, et al.
Publicado: (2004)

AR–PDEF pathway promotes tumour proliferation and upregulates MYC-mediated gene transcription by promoting MAD1 degradation in ER-negative breast cancer
por: Cao, Lu, et al.
Publicado: (2018)

Eukaryotic Translation Initiation Factor 4 Gamma 1 (eIF4G1) is upregulated during Prostate cancer progression and modulates cell growth and metastasis
por: Jaiswal, Praveen Kumar, et al.
Publicado: (2018)

Regulation of SPDEF expression by DNA methylation in advanced prostate cancer
por: Vatanmakanian, Mousa, et al.
Publicado: (2023)

Eukaryotic Translation Initiation Factor 4 Gamma 1 (EIF4G1): a target for cancer therapeutic intervention?
por: Jaiswal, Praveen Kumar, et al.
Publicado: (2019)

Giloy Ghanvati (Tinospora cordifolia (Willd.) Hook. f. and Thomson) Reversed SARS-CoV-2 Viral Spike-Protein Induced Disease Phenotype in the Xenotransplant Model of Humanized Zebrafish
por: Balkrishna, Acharya, et al.
Publicado: (2021)

The Antioxidant, MnTE-2-PyP, Prevents Side-Effects Incurred by Prostate Cancer Irradiation
por: Oberley-Deegan, Rebecca E., et al.
Publicado: (2012)

Targeting the TLK1/NEK1 DDR axis with Thioridazine suppresses outgrowth of androgen independent prostate tumors
por: Singh, Vibha, et al.
Publicado: (2019)

The ETS family member GABPα modulates androgen receptor signalling and mediates an aggressive phenotype in prostate cancer
por: Sharma, Naomi L., et al.
Publicado: (2014)

Supercritical Fluid Extract of Putranjiva roxburghii Wall. Seeds Mitigates Fertility Impairment in a Zebrafish Model
por: Balkrishna, Acharya, et al.
Publicado: (2021)

The Role of Adhesion Molecules as Biomarkers for the Aggressive Prostate Cancer Phenotype
por: Morgan, Claire, et al.
Publicado: (2013)

Loss of ABHD5 promotes the aggressiveness of prostate cancer cells
por: Chen, Guohua, et al.
Publicado: (2017)

Calcio-Herbal Medicine Divya-Swasari-Vati Ameliorates SARS-CoV-2 Spike Protein-Induced Pathological Features and Inflammation in Humanized Zebrafish Model by Moderating IL-6 and TNF-α Cytokines
por: Balkrishna, Acharya, et al.
Publicado: (2020)

Expression of FGD4 positively correlates with the aggressive phenotype of prostate cancer
por: Bossan, Alexia, et al.
Publicado: (2018)

Association of prostate volume with incidence and aggressiveness of prostate cancer
por: Al-Khalil, Shadi, et al.
Publicado: (2016)

Decreased ATM Protein Expression Is Substantiated with PTEN Loss in Defining Aggressive Phenotype of Prostate Cancer Associated with Lethal Disease
por: Walker, Simon R., et al.
Publicado: (2021)

Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation
por: Moroz, Andrei, et al.
Publicado: (2013)

Establishment and Characterization of Brain Cancer Primary Cell Cultures From Patients to Enable Phenotypic Screening for New Drugs
por: dePadua, Michelle, et al.
Publicado: (2022)

Downstream Neighbor of SON (DONSON) Expression Is Enhanced in Phenotypically Aggressive Prostate Cancers
por: Klümper, Niklas, et al.
Publicado: (2020)

Phenotype plasticity and altered sensitivity to chemotherapeutic agents in aggressive prostate cancer cells
por: Paxson, Allan I., et al.
Publicado: (2023)

Loss of PLZF Expression in Prostate Cancer by Immunohistochemistry Correlates with Tumor Aggressiveness and Metastasis
por: Xiao, Guang-Qian, et al.
Publicado: (2015)

Loss of microRNA-135b Enhances Bone Metastasis in Prostate Cancer and Predicts Aggressiveness in Human Prostate Samples
por: Olivan, Mireia, et al.
Publicado: (2021)

Neuroendocrine and Aggressive-Variant Prostate Cancer
por: Spetsieris, Nicholas, et al.
Publicado: (2020)

Biomarkers of Aggressive Prostate Cancer at Diagnosis
por: Boehm, Brock E., et al.
Publicado: (2023)

Intraductal prostate cancer: An aggressive subset of prostate cancers? Immunophenotypic evaluation
por: Faviana, Pinuccia, et al.
Publicado: (2022)

Prostate cancer aggressiveness and financial toxicity among prostate cancer patients
por: KC, Madhav, et al.
Publicado: (2022)

Rat Prostate Tumor Cells Progress in the Bone Microenvironment to a Highly Aggressive Phenotype()
por: Bergström, Sofia Halin, et al.
Publicado: (2016)

The transcription factor ZEB1 promotes an aggressive phenotype in prostate cancer cell lines
por: Orellana-Serradell, Octavio, et al.
Publicado: (2018)

Serum Fucosylated Prostate-specific Antigen (PSA) Improves the Differentiation of Aggressive from Non-aggressive Prostate Cancers
por: Li, Qing Kay, et al.
Publicado: (2015)

PRL-3 increases the aggressive phenotype of prostate cancer cells in vitro and its expression correlates with high-grade prostate tumors in patients
por: Edwards, Donna R., et al.
Publicado: (2017)

Genotype-to-Phenotype Associations in the Aggressive Variant Prostate Cancer Molecular Profile (AVPC-m) Components
por: Soundararajan, Rama, et al.
Publicado: (2022)

Dysfunctional Lipid Metabolism—The Basis for How Genetic Abnormalities Express the Phenotype of Aggressive Prostate Cancer
por: Alberto, Matthew, et al.
Publicado: (2023)

RANKL/RANK/MMP-1 Molecular Triad Contributes to the Metastatic Phenotype of Breast and Prostate Cancer Cells In Vitro
por: Casimiro, Sandra, et al.
Publicado: (2013)

Blood-Based Biomarkers of Aggressive Prostate Cancer
por: Liong, Men Long, et al.
Publicado: (2012)

Src: Marker or Actor in Prostate Cancer Aggressiveness
por: Vlaeminck-Guillem, Virginie, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tqpeqlb24n6kgg2bfh59ad9pvp